A Chinese American crossed oceans to receive life-saving treatment for gastric cancer at Sir Run Run Shaw Hospital. Having failed multiple therapies in the US, he was treated with CT041, the world’s first approved CAR-T therapy for solid tumors. Led by Dr. Zheng Yu’s team. The patient tolerated treatment well; his wound healed and condition improved. Targeting CLDN18.2, CT041 cuts progression or death risk by 63% for heavily pre-treated gastric cancer patients.

The 1st International Oncology Treatment Forum was held in Foshan by Fosun Health, gathering 200+ oncology experts from 15 nations. The Global Oncology Collaboration Alliance was launched to build cross‑border tele‑consultation and second‑opinion networks. Sessions covered precision radiotherapy, CyberKnife, BNCT, CAR‑T and TCM‑integrated oncology. Fosun Health also unveiled its end‑to‑end navigation model for overseas cancer patients, advancing patient‑centred global medical